Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on September 19, 2024, reports on the Annual General Meeting of Shareholders held on September 17, 2024. The filing confirms that all proposals presented to shareholders were approved by the requisite majority under Israeli law and the Company's articles of association.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance report regarding shareholder voting results and does not contain financial performance data.
Material Changes
There are no material financial changes reported in this filing. The primary event is the successful ratification of shareholder proposals at the annual meeting.
Guidance, Outlook, and Risks
The filing contains no management commentary on future guidance, outlook, risks, contingencies, or unusual items. It strictly documents the outcome of the shareholder vote.
Key Facts for Investors
- All shareholder proposals at the September 17, 2024, Annual General Meeting were approved.
- 157,503,922 ordinary shares were present or represented by proxy at the meeting.
- Attendance represented approximately 75.65% of the issued and outstanding ordinary shares as of the record date.
- This report is incorporated by reference into the Company's registration statements on Form S-8 and Form F-3.